Debasish Tripathy, Milana V. Dolezal, Vandana G. Abramson, Namita Chittoria, Sima Ehsani, Richard G. Pestell, Hope S. Rugo, Hallgeir Rui, Daniel L. Adams, Joseph Meidling, Max Lataillade, Jacob P. Lalezari. "Safety and 5-year survival following treatment with leronlimab plus physician’s choice combination therapy in patients with metastatic triple-negative breast cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e13109